Efficacy and Safety of Paliperidone in Schizophrenia - Bangladesh Study
Status:
NOT_YET_RECRUITING
Trial end date:
2026-07-31
Target enrollment:
Participant gender:
Summary
This is a single-arm, open-label, multicenter, prospective quasi-experimental study evaluating the efficacy and safety of extended-release paliperidone in adults with schizophrenia in Bangladesh. The study will assess psychotic symptom improvement using the PANSS scale, monitor side effects using GASS, and evaluate quality of life via WHOQOL-BREF.
Phase:
PHASE4
Details
Lead Sponsor:
Sher-E-Bangla Medical College
Collaborators:
ACI Pharmaceuticals Dr. M M Jalal Uddin Dr.Ahsan Aziz Sarkar US-Bangla Medical College Hospital